Interventional Cardiology & Peripheral Vascular Devices Market - 2032

Interventional Cardiology & Peripheral Vascular Devices Market - By Product (Interventional Catheters, Guidewires, Stents, PTCA Balloons, Atherectomy Devices, Embolic Protection Devices), Application, End-use & Global Forecast to 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3.1&nbsp;&nbsp;&nbsp; North America

1.3.2&nbsp;&nbsp;&nbsp; Europe

1.3.3&nbsp;&nbsp;&nbsp; Asia Pacific

1.3.4&nbsp;&nbsp;&nbsp; Latin America

1.3.5&nbsp;&nbsp;&nbsp; MEA

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Interventional cardiology &amp; peripheral vascular devices industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Product trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; End-use trends

2.1.5&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Interventional Cardiology &amp; Peripheral Vascular Devices Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing prevalence of vascular diseases worldwide

3.2.1.2&nbsp;&nbsp;&nbsp;Technological advancements in peripheral vascular devices

3.2.1.3&nbsp;&nbsp;&nbsp;Rising adoption of minimally invasive procedures

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing government spending pertaining to cardiovascular diseases burden

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory framework

3.2.2.2&nbsp;&nbsp;&nbsp;Post-procedural complications associated with devices

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product

3.3.2&nbsp;&nbsp;&nbsp; By application

3.3.3&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5.1&nbsp;&nbsp;&nbsp; U.S.

3.5.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Patent analysis

3.7&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2021

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Competitive dashboard, 2021

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis, 2021

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Interventional Cardiology &amp; Peripheral Vascular Devices Market, By Product

5.1&nbsp;&nbsp;&nbsp; Key product trends

5.2&nbsp;&nbsp;&nbsp; Interventional catheters

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Guidewires

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.4&nbsp;&nbsp;&nbsp; Stents

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.2&nbsp;&nbsp;&nbsp; Bioabsorbable stents

5.4.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.3&nbsp;&nbsp;&nbsp; Drug eluting stents

5.4.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.4&nbsp;&nbsp;&nbsp; Bare metal stents

5.4.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.5&nbsp;&nbsp;&nbsp; Others

5.4.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.5&nbsp;&nbsp;&nbsp; PTCA balloons

5.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.6&nbsp;&nbsp;&nbsp; Atherectomy devices

5.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.7&nbsp;&nbsp;&nbsp; Chronic total occlusion devices

5.7.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.8&nbsp;&nbsp;&nbsp; Synthetic surgical grafts

5.8.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.9&nbsp;&nbsp;&nbsp; Embolic protection devices

5.9.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.10&nbsp;&nbsp;&nbsp; Inferior vena cava filters

5.10.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.11&nbsp;&nbsp;&nbsp; Others

5.11.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Interventional Cardiology &amp; Peripheral Vascular Devices Market, By Application

6.1&nbsp;&nbsp;&nbsp; Key application trends

6.2&nbsp;&nbsp;&nbsp; Congenital heart defect correction

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Coronary thrombectomy

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Angioplasty

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Valvuloplasty

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.6&nbsp;&nbsp;&nbsp; Percutaneous valve repair

6.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.7&nbsp;&nbsp;&nbsp; Others

6.7.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Interventional Cardiology &amp; Peripheral Vascular Devices Market, By End-use

7.1&nbsp;&nbsp;&nbsp; Key end-use trends

7.2&nbsp;&nbsp;&nbsp; Hospital

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Others

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Interventional Cardiology &amp; Peripheral Vascular Devices Market Market, By Region

8.1&nbsp;&nbsp;&nbsp; Key regional trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Poland

8.3.7&nbsp;&nbsp;&nbsp; The Netherlands

8.3.8&nbsp;&nbsp;&nbsp; Sweden

8.3.9&nbsp;&nbsp;&nbsp; Austria

8.3.10&nbsp;&nbsp;&nbsp; Denmark

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; South Korea

8.4.5&nbsp;&nbsp;&nbsp; Australia

8.4.6&nbsp;&nbsp;&nbsp; Thailand

8.4.7&nbsp;&nbsp;&nbsp; Singapore

8.4.8&nbsp;&nbsp;&nbsp; Indonesia

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Chile

8.5.5&nbsp;&nbsp;&nbsp; Colombia

8.5.6&nbsp;&nbsp;&nbsp; Peru

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.2&nbsp;&nbsp;&nbsp; South Africa

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Israel

8.6.5&nbsp;&nbsp;&nbsp; Egypt

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.2&nbsp;&nbsp;&nbsp; Medtronic Plc

9.3&nbsp;&nbsp;&nbsp; B. Braun Melsungen AG

9.4&nbsp;&nbsp;&nbsp; Boston Scientific Corporation

9.5&nbsp;&nbsp;&nbsp; AngioDynamics

9.6&nbsp;&nbsp;&nbsp; Biotronik SE &amp; Co. KG

9.7&nbsp;&nbsp;&nbsp; Cook Medical

9.8&nbsp;&nbsp;&nbsp; W.L. Gore &amp; Associates, Inc.

9.9&nbsp;&nbsp;&nbsp; Teleflex Inc.

9.10&nbsp;&nbsp;&nbsp; Cardinal Health

9.11&nbsp;&nbsp;&nbsp; C. R. Bard (Becton Dickinson and Company) 
&nbsp;

Interventional Cardiology & Peripheral Vascular Devices Market

Inquiry Before Buying